Abstract:Abstract My lab has been working on the Hippo pathway and its regulators in cancer. Our earlier works defined the oncogenic role of TAZ/WWTR1 and the importance of TEAD in mediating TAZ-driven oncogenesis. We also resolved the crystal structure of YAP-TEAD and Vgll1-TEAD complexes offering the structural basis for their role in the Hippo pathway. Amot proteins, Wbp2, and USP9X were identified to be regulators of the Hippo pathway. Due to the importance of YAP/TAZ-TEAD complex in driving transcriptional program that is implicated in diverse human cancers, targeting TAZ, YAP, TEAD, and their complexes represents an attractive opportunity for novel cancer drug discovery. We recently reported the discovery of a central hydrophobic pocket in the YAP/TAZ-binding domain of TEAD proteins that is targetable by small-molecule inhibitors. Flufenamic acid, a nonsteroidal anti-inflammatory drug (NSAID), was shown to bind to the central pocket of TEAD and modulate its function. Studies from other labs have also shown that this pocket is physiologically occupied by palmitate via autopalmitoylation of TEAD. We therefore developed a target-based, TEAD-palmitate interaction screen that was used to select compounds occupying the palmitate-binding pocket (PBP) in TEADs. Interestingly, we identified some candidates as TEAD-binding compounds that augment YAP/TAZ-TEAD activity. The enhancement of YAP/TAZ-TEAD activity by these compounds accelerates in vivo wound closure in a cutaneous wound-healing mouse model. These results suggest that the class of TEAD-activating compounds could be exploited for use in regenerative medicine, while future search for inhibitors will serve as candidates for cancer drugs. Citation Format: Wanjin Hong. Targeting the Hippo pathway for candidate cancer therapy [abstract]. In: Proceedings of the AACR Special Conference on the Hippo Pathway: Signaling, Cancer, and Beyond; 2019 May 8-11; San Diego, CA. Philadelphia (PA): AACR; Mol Cancer Res 2020;18(8_Suppl):Abstract nr IA18.

Targeting Yap/Taz-Tead Protein-Protein Interactions Using Fragment-Based And Computational Modeling Approaches

YAP/TAZ for cancer therapy: Opportunities and challenges (Review)

Structural and functional insights into the TEAD-YAP complex in the Hippo signaling pathway

YAP/TAZ for Cancer Therapy: Opportunities and Challenges (Review).

Targeting Hippo Pathway by Specific Interruption of YAP‐TEAD Interaction Using Cyclic YAP‐like Peptides

Targeting Human Hippo TEAD Binding Interface with YAP/TAZ-Derived, Flexibility-Reduced Peptides in Gastric Cancer

Allosteric Modulation of the YAP/TAZ-TEAD Interaction by Palmitoylation and Small-Molecule Inhibitors

Abstract IA18: Targeting the Hippo Pathway for Candidate Cancer Therapy

Advances of targeting the YAP/TAZ-TEAD complex in the hippo pathway for the treatment of cancers

Direct inhibition of the YAP:TEAD interaction: an unprecedented drug discovery challenge

Targeting the Hippo Pathway for Anti-cancer Therapies.

Structural Insights into the YAP and TEAD Complex.

Leveraging the Fragment Molecular Orbital and MM-GBSA Methods in Virtual Screening for the Discovery of Novel Non-Covalent Inhibitors Targeting the TEAD Lipid Binding Pocket

Covalent disruptor of YAP-TEAD association suppresses defective hippo signaling

Integration of Mechanical and Chemical Signals by YAP and TAZ Transcription Coactivators.

Computational design and experimental confirmation of a disulfide-stapled YAP helixα1-trap derived from TEAD4 helical hairpin to selectively capture YAP α1-helix with potent antitumor activity

Abstract B11: Computational Insights on the Druggability of TEAD YAP-binding Domain

Structural Basis of YAP Recognition by TEAD4 in the Hippo Pathway.

Crystal structure of TAZ-TEAD complex reveals a distinct interaction mode from that of YAP-TEAD complex

The Hippo Pathway and YAP/TAZ-TEAD Protein-Protein Interaction as Targets for Regenerative Medicine and Cancer Treatment

Identification of Celastrol as a Novel YAP-TEAD Inhibitor for Cancer Therapy by High Throughput Screening with Ultrasensitive YAP/TAZ–TEAD Biosensors